Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cystic Fibrosis | 122 | 2024 | 1285 | 22.410 |
Why?
|
Aminophenols | 25 | 2024 | 87 | 6.080 |
Why?
|
Quinolones | 22 | 2024 | 378 | 5.130 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 26 | 2024 | 450 | 4.360 |
Why?
|
Benzodioxoles | 14 | 2024 | 75 | 3.380 |
Why?
|
Deoxyribonuclease I | 6 | 2024 | 224 | 1.790 |
Why?
|
Aminopyridines | 6 | 2021 | 573 | 1.780 |
Why?
|
Self Care | 8 | 2017 | 796 | 1.720 |
Why?
|
Achilles Tendon | 4 | 2024 | 180 | 1.320 |
Why?
|
Needs Assessment | 9 | 2021 | 1139 | 1.300 |
Why?
|
Cost of Illness | 7 | 2021 | 1937 | 1.090 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 5 | 2024 | 697 | 1.080 |
Why?
|
Telemedicine | 7 | 2024 | 3051 | 1.080 |
Why?
|
Registries | 13 | 2021 | 8209 | 1.040 |
Why?
|
Forced Expiratory Volume | 13 | 2024 | 1814 | 1.030 |
Why?
|
Parents | 8 | 2019 | 3563 | 1.000 |
Why?
|
Pulmonary Medicine | 3 | 2024 | 221 | 0.960 |
Why?
|
Respiratory Function Tests | 12 | 2021 | 1683 | 0.930 |
Why?
|
Thioglycolates | 1 | 2024 | 37 | 0.920 |
Why?
|
Polycyclic Compounds | 1 | 2024 | 29 | 0.920 |
Why?
|
Heel | 1 | 2024 | 37 | 0.910 |
Why?
|
Medication Therapy Management | 2 | 2018 | 130 | 0.870 |
Why?
|
Diterpenes | 1 | 2024 | 170 | 0.850 |
Why?
|
Models, Organizational | 4 | 2021 | 544 | 0.830 |
Why?
|
Adolescent | 80 | 2024 | 88247 | 0.820 |
Why?
|
Continuity of Patient Care | 4 | 2021 | 1067 | 0.820 |
Why?
|
Health Services Accessibility | 8 | 2021 | 5430 | 0.800 |
Why?
|
Chronic Disease | 15 | 2024 | 9310 | 0.790 |
Why?
|
Patient Compliance | 5 | 2017 | 2688 | 0.780 |
Why?
|
Child | 66 | 2024 | 80089 | 0.780 |
Why?
|
Spirometry | 2 | 2022 | 928 | 0.770 |
Why?
|
Communication Barriers | 2 | 2021 | 414 | 0.760 |
Why?
|
Locomotion | 2 | 2024 | 388 | 0.750 |
Why?
|
Lung | 17 | 2022 | 9999 | 0.740 |
Why?
|
Young Adult | 63 | 2024 | 59191 | 0.710 |
Why?
|
Deductibles and Coinsurance | 1 | 2023 | 316 | 0.710 |
Why?
|
Walking | 8 | 2024 | 1197 | 0.670 |
Why?
|
Insurance Claim Review | 3 | 2018 | 741 | 0.670 |
Why?
|
Indoles | 7 | 2024 | 1830 | 0.670 |
Why?
|
Disease Transmission, Infectious | 2 | 2021 | 561 | 0.650 |
Why?
|
Reproductive Health Services | 4 | 2023 | 87 | 0.650 |
Why?
|
Equipment and Supplies | 1 | 2021 | 273 | 0.640 |
Why?
|
Quality of Life | 16 | 2022 | 13359 | 0.630 |
Why?
|
Humans | 162 | 2024 | 760740 | 0.630 |
Why?
|
Sex Education | 1 | 2019 | 93 | 0.620 |
Why?
|
Running | 1 | 2023 | 488 | 0.610 |
Why?
|
Adult | 82 | 2024 | 220995 | 0.610 |
Why?
|
Adaptation, Psychological | 4 | 2019 | 2632 | 0.590 |
Why?
|
Stenotrophomonas maltophilia | 1 | 2017 | 18 | 0.580 |
Why?
|
Pseudomonas Infections | 5 | 2014 | 621 | 0.580 |
Why?
|
Women | 1 | 2018 | 224 | 0.540 |
Why?
|
Drug Combinations | 6 | 2024 | 2048 | 0.520 |
Why?
|
Asthma | 9 | 2017 | 6234 | 0.520 |
Why?
|
Disease Progression | 11 | 2022 | 13495 | 0.520 |
Why?
|
Health Benefit Plans, Employee | 1 | 2018 | 332 | 0.510 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2017 | 238 | 0.500 |
Why?
|
Sweat | 4 | 2021 | 56 | 0.500 |
Why?
|
Child Health Services | 1 | 2021 | 644 | 0.500 |
Why?
|
Ambulatory Care Facilities | 2 | 2021 | 934 | 0.490 |
Why?
|
Lung Diseases | 3 | 2024 | 1909 | 0.490 |
Why?
|
Home Care Services | 1 | 2021 | 648 | 0.490 |
Why?
|
Tobramycin | 2 | 2012 | 65 | 0.480 |
Why?
|
Eligibility Determination | 1 | 2018 | 421 | 0.480 |
Why?
|
Homozygote | 5 | 2022 | 1776 | 0.480 |
Why?
|
Ethics, Medical | 1 | 2019 | 783 | 0.460 |
Why?
|
Male | 96 | 2024 | 360402 | 0.460 |
Why?
|
Risk Adjustment | 1 | 2018 | 600 | 0.450 |
Why?
|
Monitoring, Physiologic | 1 | 2021 | 1780 | 0.450 |
Why?
|
Health Status | 6 | 2021 | 4076 | 0.450 |
Why?
|
Treatment Refusal | 1 | 2017 | 429 | 0.440 |
Why?
|
Female | 97 | 2024 | 392203 | 0.440 |
Why?
|
Patient Participation | 2 | 2021 | 1443 | 0.430 |
Why?
|
Health Personnel | 4 | 2023 | 3333 | 0.430 |
Why?
|
Social Perception | 1 | 2017 | 431 | 0.430 |
Why?
|
Quality Improvement | 5 | 2021 | 3801 | 0.420 |
Why?
|
Physician's Role | 1 | 2019 | 917 | 0.410 |
Why?
|
Cost Savings | 1 | 2018 | 912 | 0.410 |
Why?
|
Pseudomonas aeruginosa | 5 | 2019 | 1272 | 0.410 |
Why?
|
Cough | 5 | 2021 | 595 | 0.410 |
Why?
|
Quality of Health Care | 5 | 2021 | 4325 | 0.410 |
Why?
|
Attitude of Health Personnel | 3 | 2023 | 3882 | 0.410 |
Why?
|
Health Knowledge, Attitudes, Practice | 7 | 2024 | 4010 | 0.400 |
Why?
|
Pneumonia | 1 | 2024 | 2143 | 0.390 |
Why?
|
Health Services | 3 | 2016 | 751 | 0.390 |
Why?
|
Health Care Surveys | 2 | 2017 | 2422 | 0.390 |
Why?
|
Teaching | 1 | 2019 | 1169 | 0.370 |
Why?
|
Self Concept | 1 | 2017 | 1046 | 0.370 |
Why?
|
Ambulatory Care | 2 | 2021 | 2768 | 0.360 |
Why?
|
Drug Prescriptions | 2 | 2018 | 1669 | 0.360 |
Why?
|
Resilience, Psychological | 1 | 2018 | 787 | 0.350 |
Why?
|
United States | 30 | 2022 | 72292 | 0.340 |
Why?
|
Severity of Illness Index | 13 | 2021 | 15829 | 0.340 |
Why?
|
Ankle Joint | 2 | 2024 | 446 | 0.340 |
Why?
|
Anti-Asthmatic Agents | 2 | 2017 | 574 | 0.340 |
Why?
|
Anti-Bacterial Agents | 7 | 2024 | 7403 | 0.340 |
Why?
|
Staphylococcal Infections | 2 | 2009 | 1406 | 0.340 |
Why?
|
Sexual Behavior | 7 | 2022 | 2187 | 0.310 |
Why?
|
Recombinant Proteins | 4 | 2024 | 6520 | 0.310 |
Why?
|
Caregivers | 5 | 2024 | 2241 | 0.310 |
Why?
|
Women's Health | 1 | 2018 | 2066 | 0.310 |
Why?
|
Drug Costs | 2 | 2013 | 1183 | 0.290 |
Why?
|
Patient Advocacy | 1 | 2009 | 360 | 0.290 |
Why?
|
Sinusitis | 3 | 2021 | 991 | 0.280 |
Why?
|
Muscle, Skeletal | 5 | 2024 | 4947 | 0.280 |
Why?
|
Child, Preschool | 25 | 2024 | 42193 | 0.280 |
Why?
|
Advance Directives | 1 | 2008 | 249 | 0.270 |
Why?
|
Health Expenditures | 2 | 2018 | 2363 | 0.270 |
Why?
|
Mutation | 14 | 2023 | 30015 | 0.270 |
Why?
|
Exocrine Pancreatic Insufficiency | 3 | 2021 | 86 | 0.260 |
Why?
|
Gait | 4 | 2024 | 811 | 0.260 |
Why?
|
Time | 3 | 2021 | 545 | 0.260 |
Why?
|
Prescription Drugs | 1 | 2013 | 631 | 0.250 |
Why?
|
Adrenal Cortex Hormones | 2 | 2017 | 1878 | 0.250 |
Why?
|
Hypoglycemia | 2 | 2024 | 883 | 0.250 |
Why?
|
Longitudinal Studies | 14 | 2021 | 14599 | 0.250 |
Why?
|
Administration, Inhalation | 4 | 2017 | 1156 | 0.250 |
Why?
|
Pneumonia, Bacterial | 1 | 2008 | 315 | 0.240 |
Why?
|
Counseling | 2 | 2017 | 1538 | 0.240 |
Why?
|
Hospitalization | 6 | 2019 | 10708 | 0.240 |
Why?
|
Hyperglycemia | 2 | 2024 | 1375 | 0.230 |
Why?
|
Health Services Needs and Demand | 4 | 2021 | 1400 | 0.230 |
Why?
|
Muscle Spindles | 1 | 2023 | 15 | 0.230 |
Why?
|
Age Factors | 11 | 2021 | 18381 | 0.230 |
Why?
|
Motivation | 1 | 2014 | 2003 | 0.230 |
Why?
|
Pediatrics | 8 | 2024 | 3589 | 0.230 |
Why?
|
Men's Health | 2 | 2022 | 73 | 0.230 |
Why?
|
Employment | 1 | 2010 | 1113 | 0.220 |
Why?
|
Perception | 1 | 2010 | 1199 | 0.220 |
Why?
|
Costs and Cost Analysis | 3 | 2021 | 1663 | 0.220 |
Why?
|
Tablets | 1 | 2024 | 148 | 0.220 |
Why?
|
Glucocorticoids | 1 | 2013 | 2160 | 0.220 |
Why?
|
Shoes | 1 | 2024 | 92 | 0.220 |
Why?
|
Steroids | 1 | 2008 | 928 | 0.210 |
Why?
|
Fatigue | 2 | 2021 | 1550 | 0.210 |
Why?
|
Tendons | 2 | 2023 | 558 | 0.200 |
Why?
|
Rhinitis | 2 | 2021 | 747 | 0.200 |
Why?
|
Education, Medical | 1 | 2014 | 1725 | 0.200 |
Why?
|
Radius | 2 | 2016 | 441 | 0.200 |
Why?
|
Swimming | 1 | 2023 | 208 | 0.200 |
Why?
|
Gait Disorders, Neurologic | 1 | 2024 | 240 | 0.190 |
Why?
|
Patient Education as Topic | 2 | 2014 | 2315 | 0.190 |
Why?
|
Comparative Effectiveness Research | 2 | 2018 | 708 | 0.190 |
Why?
|
Health Policy | 1 | 2014 | 2682 | 0.190 |
Why?
|
Muscles | 2 | 2023 | 1573 | 0.190 |
Why?
|
Gastrostomy | 1 | 2024 | 323 | 0.190 |
Why?
|
Respiratory Tract Infections | 3 | 2021 | 1009 | 0.190 |
Why?
|
Advance Care Planning | 1 | 2008 | 683 | 0.190 |
Why?
|
Social Support | 3 | 2019 | 2174 | 0.180 |
Why?
|
Qualitative Research | 2 | 2024 | 3017 | 0.180 |
Why?
|
Sickness Impact Profile | 2 | 2012 | 299 | 0.180 |
Why?
|
Oximetry | 2 | 2021 | 459 | 0.170 |
Why?
|
Bone Density | 3 | 2021 | 3548 | 0.170 |
Why?
|
Dyspnea | 1 | 2008 | 1347 | 0.170 |
Why?
|
Treatment Outcome | 14 | 2024 | 64572 | 0.170 |
Why?
|
Neonatal Screening | 1 | 2024 | 597 | 0.170 |
Why?
|
Retrospective Studies | 17 | 2021 | 80583 | 0.170 |
Why?
|
Blood Glucose Self-Monitoring | 4 | 2024 | 467 | 0.160 |
Why?
|
Insurance, Health | 3 | 2023 | 2495 | 0.160 |
Why?
|
Interviews as Topic | 3 | 2017 | 2697 | 0.160 |
Why?
|
Tibia | 2 | 2016 | 1069 | 0.160 |
Why?
|
Awards and Prizes | 1 | 2023 | 360 | 0.160 |
Why?
|
Insurance Coverage | 2 | 2023 | 1937 | 0.160 |
Why?
|
Leg | 1 | 2024 | 1087 | 0.160 |
Why?
|
Fees, Pharmaceutical | 1 | 2018 | 66 | 0.160 |
Why?
|
Cross-Sectional Studies | 12 | 2022 | 26065 | 0.160 |
Why?
|
Interdisciplinary Studies | 1 | 2019 | 86 | 0.160 |
Why?
|
Crohn Disease | 2 | 2021 | 2279 | 0.160 |
Why?
|
Paranasal Sinuses | 2 | 2021 | 265 | 0.160 |
Why?
|
Organizational Innovation | 1 | 2021 | 537 | 0.150 |
Why?
|
Behavior Therapy | 1 | 2024 | 877 | 0.150 |
Why?
|
United States Food and Drug Administration | 2 | 2018 | 1661 | 0.150 |
Why?
|
Hospitals, Pediatric | 3 | 2021 | 1859 | 0.150 |
Why?
|
Middle Aged | 23 | 2022 | 220603 | 0.150 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2021 | 495 | 0.150 |
Why?
|
Unemployment | 1 | 2019 | 210 | 0.150 |
Why?
|
Radiography, Thoracic | 2 | 2015 | 1302 | 0.150 |
Why?
|
Enteral Nutrition | 1 | 2024 | 794 | 0.150 |
Why?
|
Body Image | 1 | 2022 | 639 | 0.150 |
Why?
|
Cross-Over Studies | 1 | 2024 | 2079 | 0.140 |
Why?
|
Decision Making | 2 | 2024 | 3919 | 0.140 |
Why?
|
Chlorides | 2 | 2021 | 665 | 0.140 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2015 | 1222 | 0.140 |
Why?
|
Anxiety | 4 | 2021 | 4573 | 0.140 |
Why?
|
Nutritional Status | 2 | 2015 | 1597 | 0.140 |
Why?
|
Drug Administration Schedule | 3 | 2016 | 4845 | 0.140 |
Why?
|
Health Surveys | 3 | 2019 | 4036 | 0.140 |
Why?
|
Pyrazoles | 2 | 2024 | 2008 | 0.140 |
Why?
|
Cephalosporins | 1 | 2017 | 198 | 0.140 |
Why?
|
Emigration and Immigration | 1 | 2019 | 397 | 0.140 |
Why?
|
Ibuprofen | 1 | 2018 | 229 | 0.130 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2021 | 2423 | 0.130 |
Why?
|
Pancreas | 2 | 2024 | 1691 | 0.130 |
Why?
|
Efficiency | 1 | 2019 | 476 | 0.130 |
Why?
|
Sex Factors | 5 | 2021 | 10549 | 0.130 |
Why?
|
Reimbursement Mechanisms | 1 | 2021 | 667 | 0.130 |
Why?
|
Pharmacies | 1 | 2018 | 167 | 0.130 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2023 | 1650 | 0.130 |
Why?
|
Airway Resistance | 1 | 2017 | 406 | 0.130 |
Why?
|
Patient Protection and Affordable Care Act | 2 | 2017 | 1187 | 0.130 |
Why?
|
Communication | 3 | 2018 | 3851 | 0.130 |
Why?
|
Prescriptions | 1 | 2018 | 386 | 0.130 |
Why?
|
Health Services Misuse | 1 | 2017 | 244 | 0.130 |
Why?
|
Logistic Models | 4 | 2015 | 13248 | 0.130 |
Why?
|
Infant | 12 | 2024 | 36157 | 0.130 |
Why?
|
Health Status Indicators | 1 | 2021 | 970 | 0.120 |
Why?
|
Public Policy | 1 | 2019 | 557 | 0.120 |
Why?
|
Medical History Taking | 1 | 2019 | 773 | 0.120 |
Why?
|
Cohort Studies | 8 | 2021 | 41464 | 0.120 |
Why?
|
Contraception | 1 | 2018 | 347 | 0.120 |
Why?
|
Eating | 1 | 2022 | 1535 | 0.120 |
Why?
|
Medication Adherence | 2 | 2018 | 2175 | 0.120 |
Why?
|
Sampling Studies | 2 | 2014 | 615 | 0.120 |
Why?
|
Vitamin D Deficiency | 2 | 2015 | 1388 | 0.120 |
Why?
|
Ergocalciferols | 1 | 2015 | 110 | 0.120 |
Why?
|
Knee Joint | 1 | 2023 | 1676 | 0.120 |
Why?
|
Nebulizers and Vaporizers | 1 | 2015 | 139 | 0.120 |
Why?
|
Terminal Care | 2 | 2017 | 1755 | 0.110 |
Why?
|
Directive Counseling | 1 | 2015 | 170 | 0.110 |
Why?
|
Drug Therapy, Combination | 3 | 2019 | 6305 | 0.110 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2018 | 452 | 0.110 |
Why?
|
Fertility | 1 | 2018 | 769 | 0.110 |
Why?
|
Adolescent Medicine | 1 | 2014 | 73 | 0.110 |
Why?
|
Adolescent Health Services | 1 | 2015 | 218 | 0.110 |
Why?
|
Infant, Newborn | 4 | 2024 | 26183 | 0.110 |
Why?
|
Reproducibility of Results | 6 | 2024 | 20077 | 0.110 |
Why?
|
Saline Solution, Hypertonic | 2 | 2024 | 114 | 0.110 |
Why?
|
Activities of Daily Living | 2 | 2014 | 2419 | 0.110 |
Why?
|
Physician-Patient Relations | 3 | 2011 | 3239 | 0.110 |
Why?
|
Forecasting | 2 | 2014 | 2924 | 0.110 |
Why?
|
Databases, Factual | 2 | 2019 | 7963 | 0.110 |
Why?
|
Program Development | 1 | 2019 | 1293 | 0.100 |
Why?
|
Time Factors | 4 | 2021 | 39908 | 0.100 |
Why?
|
Mechanical Phenomena | 2 | 2024 | 142 | 0.100 |
Why?
|
Airway Obstruction | 1 | 2017 | 661 | 0.100 |
Why?
|
Clinical Trials as Topic | 2 | 2021 | 7995 | 0.100 |
Why?
|
Body Composition | 1 | 2022 | 2426 | 0.100 |
Why?
|
Health Education | 1 | 2019 | 1049 | 0.100 |
Why?
|
Medically Uninsured | 1 | 2018 | 835 | 0.100 |
Why?
|
Follow-Up Studies | 7 | 2017 | 39062 | 0.100 |
Why?
|
Elasticity Imaging Techniques | 1 | 2017 | 391 | 0.100 |
Why?
|
Program Evaluation | 2 | 2018 | 2486 | 0.100 |
Why?
|
Survivors | 2 | 2016 | 2373 | 0.100 |
Why?
|
Delivery of Health Care | 2 | 2021 | 5334 | 0.100 |
Why?
|
Otolaryngology | 1 | 2019 | 693 | 0.100 |
Why?
|
Multivariate Analysis | 3 | 2015 | 12043 | 0.100 |
Why?
|
Genotype | 3 | 2021 | 12977 | 0.100 |
Why?
|
Propensity Score | 2 | 2018 | 1912 | 0.100 |
Why?
|
Feasibility Studies | 1 | 2022 | 5239 | 0.100 |
Why?
|
Patient Satisfaction | 2 | 2021 | 3451 | 0.100 |
Why?
|
Factor Analysis, Statistical | 2 | 2014 | 997 | 0.090 |
Why?
|
Pyrrolidines | 2 | 2024 | 338 | 0.090 |
Why?
|
Aging | 3 | 2024 | 8700 | 0.090 |
Why?
|
Vocational Guidance | 1 | 2010 | 14 | 0.090 |
Why?
|
Palliative Care | 2 | 2017 | 3593 | 0.090 |
Why?
|
Patient Care Planning | 1 | 2016 | 905 | 0.090 |
Why?
|
Drug Resistance | 1 | 2017 | 1594 | 0.090 |
Why?
|
Endoscopy | 1 | 2021 | 1851 | 0.090 |
Why?
|
Nut Hypersensitivity | 1 | 2010 | 33 | 0.090 |
Why?
|
Egg Hypersensitivity | 1 | 2010 | 47 | 0.090 |
Why?
|
Depression | 3 | 2020 | 8132 | 0.090 |
Why?
|
Feeding Behavior | 1 | 2022 | 3183 | 0.090 |
Why?
|
Ventilator Weaning | 1 | 2011 | 164 | 0.090 |
Why?
|
Respiratory Sounds | 2 | 2014 | 702 | 0.090 |
Why?
|
Cholecalciferol | 1 | 2015 | 553 | 0.090 |
Why?
|
Bone and Bones | 1 | 2021 | 2565 | 0.090 |
Why?
|
Self Report | 3 | 2019 | 3727 | 0.090 |
Why?
|
Patients | 2 | 2014 | 906 | 0.090 |
Why?
|
Adipose Tissue | 1 | 2022 | 3310 | 0.080 |
Why?
|
Confidentiality | 1 | 2014 | 608 | 0.080 |
Why?
|
Information Storage and Retrieval | 1 | 2015 | 819 | 0.080 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2016 | 781 | 0.080 |
Why?
|
Inhalation | 1 | 2010 | 143 | 0.080 |
Why?
|
Professional Practice | 1 | 2011 | 313 | 0.080 |
Why?
|
Foundations | 2 | 2020 | 95 | 0.080 |
Why?
|
Linear Models | 2 | 2010 | 5866 | 0.080 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2024 | 3415 | 0.080 |
Why?
|
Body Height | 1 | 2015 | 1565 | 0.080 |
Why?
|
Boston | 4 | 2015 | 9313 | 0.080 |
Why?
|
Weight Gain | 1 | 2019 | 2349 | 0.080 |
Why?
|
Colitis, Ulcerative | 1 | 2021 | 1921 | 0.080 |
Why?
|
Blood Glucose | 4 | 2024 | 6390 | 0.080 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2011 | 410 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2270 | 0.070 |
Why?
|
Respiratory Therapy | 1 | 2008 | 125 | 0.070 |
Why?
|
Ion Channel Gating | 2 | 2021 | 429 | 0.070 |
Why?
|
Lung Transplantation | 1 | 2017 | 1310 | 0.070 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2011 | 326 | 0.070 |
Why?
|
Transportation | 1 | 2009 | 217 | 0.070 |
Why?
|
Body Mass Index | 4 | 2022 | 12942 | 0.070 |
Why?
|
Absorptiometry, Photon | 3 | 2022 | 1738 | 0.070 |
Why?
|
Double-Blind Method | 2 | 2022 | 12333 | 0.070 |
Why?
|
Bronchial Neoplasms | 1 | 2007 | 110 | 0.070 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2007 | 89 | 0.070 |
Why?
|
Patient Selection | 1 | 2019 | 4237 | 0.070 |
Why?
|
Patient-Centered Care | 1 | 2017 | 1419 | 0.070 |
Why?
|
Case-Control Studies | 5 | 2022 | 22153 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 3196 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2018 | 1846 | 0.070 |
Why?
|
Internal Medicine | 1 | 2014 | 1051 | 0.070 |
Why?
|
Liver Cirrhosis | 1 | 2017 | 1927 | 0.070 |
Why?
|
Exercise | 2 | 2022 | 5886 | 0.070 |
Why?
|
Family Relations | 1 | 2008 | 315 | 0.070 |
Why?
|
Vital Capacity | 2 | 2021 | 971 | 0.070 |
Why?
|
Bacteria | 1 | 2017 | 2192 | 0.070 |
Why?
|
Massachusetts | 4 | 2014 | 8835 | 0.060 |
Why?
|
Survival Analysis | 3 | 2018 | 10072 | 0.060 |
Why?
|
Self Efficacy | 1 | 2009 | 636 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2019 | 10754 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5838 | 0.060 |
Why?
|
Mental Health | 1 | 2019 | 3253 | 0.060 |
Why?
|
Attitude to Health | 1 | 2014 | 2025 | 0.060 |
Why?
|
Affective Symptoms | 1 | 2008 | 417 | 0.060 |
Why?
|
Prospective Studies | 7 | 2024 | 54364 | 0.060 |
Why?
|
Body Weight | 1 | 2015 | 4615 | 0.060 |
Why?
|
Tomography, Emission-Computed | 1 | 2007 | 1122 | 0.060 |
Why?
|
Disabled Persons | 1 | 2014 | 1226 | 0.060 |
Why?
|
Gastroesophageal Reflux | 1 | 2011 | 821 | 0.060 |
Why?
|
Pregnancy Rate | 2 | 2017 | 648 | 0.060 |
Why?
|
Aged | 10 | 2024 | 169092 | 0.060 |
Why?
|
Bionics | 1 | 2024 | 46 | 0.060 |
Why?
|
Treatment Failure | 1 | 2010 | 2635 | 0.060 |
Why?
|
Medicaid | 1 | 2017 | 2814 | 0.060 |
Why?
|
Physicians | 4 | 2017 | 4583 | 0.060 |
Why?
|
Necrosis | 1 | 2008 | 1610 | 0.050 |
Why?
|
Prevalence | 4 | 2021 | 15702 | 0.050 |
Why?
|
Risk Factors | 5 | 2018 | 74128 | 0.050 |
Why?
|
Biofeedback, Psychology | 1 | 2023 | 116 | 0.050 |
Why?
|
Data Collection | 2 | 2011 | 3316 | 0.050 |
Why?
|
Drug Monitoring | 2 | 2019 | 960 | 0.050 |
Why?
|
Insulin Infusion Systems | 1 | 2024 | 217 | 0.050 |
Why?
|
Drainage | 1 | 2008 | 1156 | 0.050 |
Why?
|
Fractures, Bone | 1 | 2014 | 2045 | 0.050 |
Why?
|
Cardiology | 1 | 2012 | 1656 | 0.050 |
Why?
|
Knee | 1 | 2023 | 279 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8652 | 0.050 |
Why?
|
Contraceptive Agents | 1 | 2022 | 144 | 0.050 |
Why?
|
Pyridines | 2 | 2024 | 2875 | 0.050 |
Why?
|
Pancreatic Elastase | 1 | 2021 | 127 | 0.050 |
Why?
|
Family | 2 | 2011 | 3193 | 0.040 |
Why?
|
Respiration, Artificial | 1 | 2011 | 2630 | 0.040 |
Why?
|
Schools | 1 | 2009 | 1483 | 0.040 |
Why?
|
Regression Analysis | 1 | 2009 | 6339 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2008 | 6223 | 0.040 |
Why?
|
Biomedical Research | 1 | 2015 | 3426 | 0.040 |
Why?
|
Research Design | 1 | 2015 | 6174 | 0.040 |
Why?
|
Electromyography | 1 | 2024 | 1392 | 0.040 |
Why?
|
Phenotype | 1 | 2017 | 16572 | 0.040 |
Why?
|
Postural Balance | 1 | 2024 | 622 | 0.040 |
Why?
|
Drug Administration Routes | 1 | 2019 | 150 | 0.040 |
Why?
|
Posture | 1 | 2023 | 956 | 0.040 |
Why?
|
Risk Assessment | 2 | 2018 | 23974 | 0.040 |
Why?
|
Quinolines | 1 | 2024 | 764 | 0.040 |
Why?
|
Information Dissemination | 1 | 2007 | 1126 | 0.040 |
Why?
|
Preoperative Period | 1 | 2021 | 550 | 0.040 |
Why?
|
Otitis Media | 1 | 2021 | 286 | 0.040 |
Why?
|
Biological Availability | 1 | 2019 | 389 | 0.040 |
Why?
|
Israel | 1 | 2021 | 716 | 0.040 |
Why?
|
Primary Health Care | 1 | 2015 | 4677 | 0.040 |
Why?
|
Transaminases | 1 | 2019 | 199 | 0.040 |
Why?
|
Clinical Competence | 1 | 2014 | 4790 | 0.040 |
Why?
|
Proportional Hazards Models | 3 | 2018 | 12448 | 0.040 |
Why?
|
Oxygen Consumption | 1 | 2024 | 1866 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12143 | 0.040 |
Why?
|
Diet Surveys | 1 | 2022 | 1161 | 0.040 |
Why?
|
Vomiting | 1 | 2021 | 651 | 0.040 |
Why?
|
Drug Substitution | 1 | 2020 | 290 | 0.040 |
Why?
|
Liver Function Tests | 1 | 2019 | 524 | 0.040 |
Why?
|
Mental Disorders | 1 | 2017 | 6826 | 0.040 |
Why?
|
Germany | 1 | 2019 | 872 | 0.040 |
Why?
|
North America | 1 | 2021 | 1273 | 0.040 |
Why?
|
Australia | 1 | 2021 | 1249 | 0.040 |
Why?
|
Forced Expiratory Flow Rates | 1 | 2017 | 75 | 0.040 |
Why?
|
Cost-Benefit Analysis | 1 | 2010 | 5493 | 0.040 |
Why?
|
Health Care Costs | 1 | 2010 | 3238 | 0.030 |
Why?
|
Sodium Chloride | 1 | 2019 | 586 | 0.030 |
Why?
|
Family Health | 1 | 2021 | 1253 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 3 | 2016 | 20556 | 0.030 |
Why?
|
Half-Life | 1 | 2017 | 650 | 0.030 |
Why?
|
Movement | 1 | 2023 | 1476 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1739 | 0.030 |
Why?
|
Postoperative Period | 1 | 2021 | 1812 | 0.030 |
Why?
|
Heart Defects, Congenital | 1 | 2012 | 4671 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 1997 | 346 | 0.030 |
Why?
|
Audiometry | 1 | 2016 | 252 | 0.030 |
Why?
|
Lower Extremity | 1 | 2023 | 1200 | 0.030 |
Why?
|
Self-Assessment | 1 | 2017 | 399 | 0.030 |
Why?
|
Obesity | 1 | 2017 | 12934 | 0.030 |
Why?
|
Survival Rate | 2 | 2020 | 12719 | 0.030 |
Why?
|
Morbidity | 1 | 2019 | 1750 | 0.030 |
Why?
|
New England | 1 | 2017 | 1050 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2018 | 7805 | 0.030 |
Why?
|
Europe | 1 | 2021 | 3415 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2017 | 982 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2010 | 15250 | 0.030 |
Why?
|
Patient Care Management | 1 | 2017 | 302 | 0.030 |
Why?
|
North Carolina | 1 | 2014 | 322 | 0.030 |
Why?
|
Hemoptysis | 1 | 2014 | 151 | 0.030 |
Why?
|
Energy Metabolism | 1 | 2024 | 2878 | 0.030 |
Why?
|
Fever | 1 | 2021 | 1618 | 0.030 |
Why?
|
Pregnancy | 3 | 2022 | 29869 | 0.030 |
Why?
|
Immunophenotyping | 1 | 1997 | 1864 | 0.030 |
Why?
|
Sputum | 1 | 2014 | 506 | 0.030 |
Why?
|
Psychometrics | 2 | 2012 | 3062 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2017 | 1700 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2021 | 2570 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 1997 | 1409 | 0.020 |
Why?
|
Age Distribution | 1 | 2017 | 2872 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2017 | 1936 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2024 | 3085 | 0.020 |
Why?
|
Vitamin D | 2 | 2015 | 3301 | 0.020 |
Why?
|
Age of Onset | 1 | 2017 | 3303 | 0.020 |
Why?
|
Esophageal pH Monitoring | 1 | 2011 | 203 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 2010 | 7873 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2189 | 0.020 |
Why?
|
Prognosis | 3 | 2019 | 29601 | 0.020 |
Why?
|
Vital Signs | 1 | 2011 | 144 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2013 | 1575 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 1997 | 1797 | 0.020 |
Why?
|
Comorbidity | 2 | 2017 | 10507 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2015 | 14649 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3575 | 0.020 |
Why?
|
Insulin | 1 | 2024 | 6593 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2017 | 1457 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 1997 | 2191 | 0.020 |
Why?
|
Referral and Consultation | 2 | 2012 | 3599 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6473 | 0.020 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2010 | 393 | 0.020 |
Why?
|
Observer Variation | 1 | 2013 | 2607 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2014 | 1502 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 22131 | 0.020 |
Why?
|
Administration, Oral | 1 | 2015 | 4010 | 0.020 |
Why?
|
Suicidal Ideation | 1 | 2017 | 1447 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2011 | 2495 | 0.020 |
Why?
|
Vitamins | 1 | 2015 | 1635 | 0.020 |
Why?
|
Proton Pump Inhibitors | 1 | 2011 | 533 | 0.020 |
Why?
|
Community Health Centers | 1 | 2010 | 460 | 0.020 |
Why?
|
Hospitals | 1 | 2019 | 3879 | 0.020 |
Why?
|
Disease Management | 1 | 2015 | 2506 | 0.010 |
Why?
|
Pilot Projects | 1 | 2017 | 8619 | 0.010 |
Why?
|
Poverty | 1 | 2015 | 2692 | 0.010 |
Why?
|
Weight Loss | 1 | 2014 | 2682 | 0.010 |
Why?
|
Respiratory Insufficiency | 1 | 2011 | 1230 | 0.010 |
Why?
|
Cytokines | 1 | 1997 | 7373 | 0.010 |
Why?
|
Odds Ratio | 1 | 2014 | 9644 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2014 | 3820 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2014 | 4533 | 0.010 |
Why?
|
Mass Screening | 1 | 2017 | 5425 | 0.010 |
Why?
|
Curriculum | 1 | 2015 | 3739 | 0.010 |
Why?
|
Patient Care Team | 1 | 2011 | 2515 | 0.010 |
Why?
|
Premature Birth | 1 | 2011 | 1782 | 0.010 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2007 | 2008 | 0.010 |
Why?
|
Gene Rearrangement, delta-Chain T-Cell Antigen Receptor | 1 | 1997 | 15 | 0.010 |
Why?
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1997 | 40 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2007 | 2650 | 0.010 |
Why?
|
Inflammation | 1 | 2014 | 10759 | 0.010 |
Why?
|
Clone Cells | 1 | 1997 | 1657 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2007 | 12966 | 0.010 |
Why?
|
Cell Line | 1 | 1997 | 15577 | 0.000 |
Why?
|